SCHEMBL18503979

SCHEMBL18503979

c1ccc(-c2cccc(-c3cccc(-c4cccc(-c5cccc(-c6cc7ccccc7c(-c7ccncc7)n6)c5)c4)c3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.47
NOTUM Q6P988 1/20 0.46
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 4/20 0.45
MAPT P10636 3/20 0.45
HPGD P15428 2/20 0.45
PRKCH P24723 1/20 0.44
PRKCE Q02156 1/20 0.44
DHODH Q02127 1/20 0.43
CDC7 O00311 1/20 0.42
IMPDH2 P12268 1/20 0.41
MAPK13 O15264 3/20 0.41
MAPK12 P53778 3/20 0.41
MAPK11 Q15759 3/20 0.41
MAPK14 Q16539 3/20 0.41
GCGR P47871 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18504021 0.98 MKNK1 (0.46) MKNK1NOTUMKDM4EALDH1A1MAPT
SCHEMBL18503964 0.98 MKNK1 (0.49) MKNK1NOTUMKDM4EALDH1A1MAPT
SCHEMBL18504023 0.97 MKNK1 (0.48) MKNK1NOTUMKDM4EALDH1A1MAPT
SCHEMBL18503942 0.92 KDM4E (0.45) KDM4EALDH1A1MAPTHPGDDHODH
SCHEMBL18504081 0.92 MKNK1 (0.46) MKNK1NOTUMKDM4EALDH1A1MAPT
SCHEMBL18503945 0.91 KDM4E (0.44) KDM4EALDH1A1MAPTHPGDDHODH
SCHEMBL18503994 0.91 KDM4E (0.44) KDM4EALDH1A1MAPTHPGDDHODH
SCHEMBL10882283 0.91 KDM4E (0.52) MKNK1NOTUMKDM4EALDH1A1MAPT
SCHEMBL18504077 0.90 MKNK1 (0.43) MKNK1KDM4EALDH1A1MAPTHPGD
SCHEMBL18503996 0.89 KDM4E (0.42) KDM4EALDH1A1MAPTHPGDDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device OXER1, OCIAD1, OCIAD2 MKNK1 2201/4885NOTUM 1295/4885KDM4E 4289/4885
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OCIAD2 MKNK1 2201/4885NOTUM 1295/4885KDM4E 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.